Ir-Catalyzed Asymmetric Hydrogenation of -Alkylidene -Lactams and Cyclobutanones

被引:40
作者
Xia, Jingzhao [1 ]
Nie, Yu [2 ]
Yang, Guoqiang [2 ]
Liu, Yangang [1 ,2 ]
Gridnev, Ilya D. [3 ]
Zhang, Wanbin [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai Key Lab Mol Engn Chiral Drugs, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Chem & Chem Engn, 800 Dongchuan Rd, Shanghai 200240, Peoples R China
[3] Tohoku Univ, Grad Sch Sci, Dept Chem, Aoba Ku, Aramaki 3-6, Sendai, Miyagi 9808578, Japan
基金
中国国家自然科学基金;
关键词
beta-lactam; cyclobutanone; iridium; phosphine-oxazoline ligand; asymmetric hydrogenation; HIGHLY ENANTIOSELECTIVE HYDROGENATION; ALPHA; BETA-UNSATURATED CARBONYL-COMPOUNDS; PHOSPHINE-OXAZOLINE LIGANDS; CHIRAL DIPHOSPHINE LIGANDS; BETA-LACTAMS; IRIDIUM CATALYSTS; PHOSPHORAMIDITE LIGANDS; TRISUBSTITUTED OLEFINS; ALLYLIC ALKYLATION; KETONES;
D O I
10.1002/cjoc.201800088
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Chiral -lactams and cyclobutanones are present in numerous natural and pharmaceutical products. The stereoselective construction of chiral four-membered cyclic compounds is an ongoing challenge for the chemical community. Herein, we report a highly stereocontrolled construction of four-membered ring (mini-sized) -lactams and cyclobutanones via an Ir/In-BiphPHOX-catalyzed asymmetric hydrogenation, providing the corresponding optically active four-membered ring carbonyl products bearing an -chiral carbon center with excellent yields (up to 99%) and enantioselectivities (up to 98%) under mild reaction conditions (1.02.5 bar H-2 for 1.010 h). The reaction presents wide substrate scope. Diverse transformations of the catalyzed products were also conducted to show the potential utility of this protocol.
引用
收藏
页码:612 / 618
页数:7
相关论文
共 93 条
[1]   Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen [J].
Adlington, RM ;
Baldwin, JE ;
Becker, GW ;
Chen, BN ;
Cheng, LF ;
Cooper, SL ;
Hermann, RB ;
Howe, TJ ;
McCoull, W ;
McNulty, AM ;
Neubauer, BL ;
Pritchard, GJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (10) :1491-1508
[2]   β-lactams:: Versatile building blocks for the stereoselective synthesis of non-β-lactam products [J].
Alcaide, Benito ;
Almendros, Pedro ;
Aragoncillo, Cristina .
CHEMICAL REVIEWS, 2007, 107 (11) :4437-4492
[3]   Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors [J].
Aoyama, Y ;
Uenaka, M ;
Kii, M ;
Tanaka, M ;
Konoike, T ;
Hayasaki-Kajiwara, Y ;
Naya, N ;
Nakajima, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (11) :3065-3075
[4]  
Blackmond DG, 2000, CHIRALITY, V12, P442, DOI 10.1002/(SICI)1520-636X(2000)12:5/6<442::AID-CHIR25>3.0.CO
[5]  
2-F
[6]  
Blankenstein J, 2001, ANGEW CHEM INT EDIT, V40, P4445, DOI 10.1002/1521-3773(20011203)40:23<4445::AID-ANIE4445>3.0.CO
[7]  
2-V
[8]   Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry [J].
Bull, James A. ;
Croft, Rosemary A. ;
Davis, Owen A. ;
Doran, Robert ;
Morgan, Kate F. .
CHEMICAL REVIEWS, 2016, 116 (19) :12150-12233
[9]   Synthesis of chiral cyclobutanes via rhodium/diene-catalyzed asymmetric 1,4-addition: a dramatic ligand effect on the diastereoselectivity [J].
Chen, Ya-Jing ;
Hu, Tian-Jiao ;
Feng, Chen-Guo ;
Lin, Guo-Qiang .
CHEMICAL COMMUNICATIONS, 2015, 51 (42) :8773-8776
[10]   Catalytic homogeneous asymmetric hydrogenations of largely unfunctionalized alkenes [J].
Cui, XH ;
Burgess, K .
CHEMICAL REVIEWS, 2005, 105 (09) :3272-3296